Psychedelic Stocks: Is the Potential Upside an Illusion?

Описание: #Psychedelics show promise as a way to treat #MentalHealth problems such as treatment-resistant depression. Investors have taken notice, but psychedelic stocks may not be the pot of gold they're perceived to be. The first psychedelic drug to be approved, Spravato, is said to be overpriced while offering questionable efficacy. Until JNJ tells us how much money they've made off of Spravato, we just won't know for sure. In the meantime, there's one thing every psychedelic drug company needs - a big pharma partner. Widespread adoption of psychedelic therapeutics can only happen if the industry chooses affordable price points and makes administration methods more convenient. Given society’s growing acceptance of psychedelics, there’s also the black market to contend with. If micro-dosing goes mainstream enough, there’s a certain percentage of the market that will be lost to that avenue. While there are numerous other indications that can be targeted by psychedelics, they’ll need the blessings of big pharma before realizing any success stories. We're passing on psychedelic stocks because the risks seem to outweigh the rewards.

RESEARCH PIECES USED IN THIS VIDEO:
1. Is the Potential of Psychedelic Stocks an Illusion?
https://www.nanalyze.com/2022/08/pote...
2. Investing in Psychedelics with MindMed Stock
https://www.nanalyze.com/2021/03/mind...
3. ATAI Life Sciences Stock – A Psychedelic IP Powerhouse
https://www.nanalyze.com/2021/04/atai...
4.Invest in Psilocybin Therapy with Compass Pathways Stock
https://www.nanalyze.com/2021/01/psil...

CHAPTERS:
00:00 Intro
01:00 What are psychedelics?
02:53 The psychedelic opportunity
04:19 A list of 10 psychedelic stocks
05:09 Three psychedelic stocks we watch
07:06 Depression and big pharma
08:50 Johnson & Johnson and Spravato
11:46 The growing popularity of microdosing
13:19 Conclusion

ABOUT US:
This video is brought to you by Nanalyze, a media and research firm founded by finance professionals with decades of experience. We share insights about #DisruptiveTechnology #stocks in a language that is future-proof and easy to understand.

Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30-day trial of our monthly subscription with no strings attached: https://www.nanalyze.com/become-a-nan...

#PsychedelicStocks #nanalyze